The Role of Oral Verapamil in Preventing Radial Spasm During Transradial Angiography
Catheterization and Cardiovascular Interventions · 2025-08 · 106 (2) · 1247-1254
DOI: 10.1002/ccd.31675 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 08.06.2025. Verfasst von Sefa Sural und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Faculty of Medicine, Istinye University, Sariyer, Istanbul, Turkey. Hauptthemen laut MEDLINE: Verapamil, Radial Artery, Spasm, Cardiac Catheterization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Radial artery spasm (RAS) is the most common complication of transradial cardiac catheterization (TRA), potentially leading to procedural failure, crossover to an alternative access site, and increased patient discomfort. Preventing RAS is critical for procedural success and safety.
Aims
To evaluate whether pre‐procedural administration of oral verapamil reduces the incidence of clinical and ultrasound‐defined radial artery spasm in patients undergoing TRA.
Methods
We conducted a prospective, randomized clinical trial (NCT06447688) comparing 120 mg of oral verapamil with placebo administered 2 h before the procedure. The primary endpoints were the incidence of clinical RAS and ultrasound‐based radial artery area change. Secondary endpoints included procedural success, contrast volume, dose area product, and fluoroscopy time.
Results
Among 231 screened patients, 150 were randomized (75 verapamil, 75 placebo). The verapamil group showed significantly lower rates of clinical RAS (4% vs. 30.7%, p < 0.001) and ultrasonographically defined RAS (10.7% vs. 48%, p < 0.001). In addition, reductions in proximal and middle radial artery area were significantly smaller in the verapamil group ( p < 0.001 for both). No significant differences were observed in procedural success, fluoroscopy time, radiation dose, or contrast volume.
Conclusion
Oral verapamil administered 2 h before TRA significantly reduces the rate of radial artery spasm and vasoconstriction. This strategy may improve patient comfort and procedural outcomes without increasing adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Faculty of Medicine, Istinye University, Sariyer, Istanbul, Turkey.
- Department of Radiology, Faculty of Medicine, Istinye University, Sariyer, Istanbul, Turkey.
- Department of Cardiology, Mersin City Training and Research Hospital, Mersin, Turkey.
- Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
- Cardiology Department, Biruni University School of Medicine, Istanbul, Turkey.
ORCID-Profile: Sefa Sural, Mehmet Ercüment Döğen, Baris Duzel, Ozkan Karaca, Emmanouil S Brilakis, Sevket Gorgulu
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Sural, S., Döğen, M. E., Duzel, B., Karaca, O., Brilakis, E. S., & Gorgulu, S. (2025). The Role of Oral Verapamil in Preventing Radial Spasm During Transradial Angiography. Catheterization and Cardiovascular Interventions, 106(2), 1247-1254. https://doi.org/10.1002/ccd.31675
Vancouver
Sural S, Döğen ME, Duzel B, Karaca O, Brilakis ES, Gorgulu S. The Role of Oral Verapamil in Preventing Radial Spasm During Transradial Angiography. Catheterization and Cardiovascular Interventions. 2025;106(2):1247-1254. doi:10.1002/ccd.31675
BibTeX
@article{Sural2025,
author = {Sural, Sefa and Döğen, Mehmet Ercüment and Duzel, Baris and Karaca, Ozkan and Brilakis, Emmanouil S and Gorgulu, Sevket},
title = {The Role of Oral Verapamil in Preventing Radial Spasm During Transradial Angiography},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
volume = {106},
number = {2},
pages = {1247--1254},
doi = {10.1002/ccd.31675}
}
EUVIMED